Similar articles for PMID: 20631076

Year	Number of Results
1993	1
1998	1
2001	3
2002	2
2003	4
2004	2
2006	1
2007	2
2008	2
2009	8
2010	13
2011	10
2012	4
2013	4
2014	10
2015	8
2016	5
2017	2
2018	2
2019	5
2020	2
2021	1
2024	0

1

FOXO3 encodes a carcinogen-activated transcription factor frequently deleted in early-stage lung adenocarcinoma.

Mikse OR, Blake DC Jr, Jones NR, Sun YW, Amin S, Gallagher CJ, Lazarus P, Weisz J, Herzog CR. Mikse OR, et al. Cancer Res. 2010 Aug 1;70(15):6205-15. doi: 10.1158/0008-5472.CAN-09-4008. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631076

2

FOXO3a elicits a pro-apoptotic transcription program and cellular response to human lung carcinogen nicotine-derived nitrosaminoketone (NNK).

Blake DC Jr, Mikse OR, Freeman WM, Herzog CR. Blake DC Jr, et al. Lung Cancer. 2010 Jan;67(1):37-47. doi: 10.1016/j.lungcan.2009.03.013. Lung Cancer. 2010. PMID: 19380174

3

FoxO3a gene is a target of deletion in mouse lung adenocarcinoma.

Herzog CR, Blake DC Jr, Mikse OR, Grigoryeva LS, Gundermann EL. Herzog CR, et al. Oncol Rep. 2009 Oct;22(4):837-43. doi: 10.3892/or_00000507. Oncol Rep. 2009. PMID: 19724863

4

The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.

Renault VM, Thekkat PU, Hoang KL, White JL, Brady CA, Kenzelmann Broz D, Venturelli OS, Johnson TM, Oskoui PR, Xuan Z, Santo EE, Zhang MQ, Vogel H, Attardi LD, Brunet A. Renault VM, et al. Oncogene. 2011 Jul 21;30(29):3207-21. doi: 10.1038/onc.2011.35. Epub 2011 Mar 21. Oncogene. 2011. PMID: 21423206 Free PMC article.

5

Adenylosuccinate synthetase 1 gene is a novel target of deletion in lung adenocarcinoma.

Miller JC, Blake DC Jr, Herzog CR. Miller JC, et al. Mol Carcinog. 2009 Dec;48(12):1116-22. doi: 10.1002/mc.20563. Mol Carcinog. 2009. PMID: 19603421

6

The carcinogen (7R,8S)-dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene induces Cdc25B expression in human bronchial and lung cancer cells.

Oguri T, Singh SV, Nemoto K, Lazo JS. Oguri T, et al. Cancer Res. 2003 Feb 15;63(4):771-5. Cancer Res. 2003. PMID: 12591724

7

LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.

Ekizoglu S, Dalay N, Karaman E, Akdeniz D, Ozaydin A, Buyru N. Ekizoglu S, et al. Transl Res. 2013 Aug;162(2):122-9. doi: 10.1016/j.trsl.2013.06.001. Epub 2013 Jun 25. Transl Res. 2013. PMID: 23810581

8

Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.

Lu M, Hartmann D, Braren R, Gupta A, Wang B, Wang Y, Mogler C, Cheng Z, Wirth T, Friess H, Kleeff J, Hüser N, Sunami Y. Lu M, et al. BMC Cancer. 2019 Sep 5;19(1):887. doi: 10.1186/s12885-019-6110-6. BMC Cancer. 2019. PMID: 31488102 Free PMC article.

9

FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms.

Czymai T, Viemann D, Sticht C, Molema G, Goebeler M, Schmidt M. Czymai T, et al. J Biol Chem. 2010 Apr 2;285(14):10163-78. doi: 10.1074/jbc.M109.056663. Epub 2010 Feb 1. J Biol Chem. 2010. PMID: 20123982 Free PMC article.

10

The role of FOXO3 in DNA damage response in thyrocytes.

Klagge A, Weidinger C, Krause K, Jessnitzer B, Gutknecht M, Fuhrer D. Klagge A, et al. Endocr Relat Cancer. 2011 Aug 30;18(5):555-64. doi: 10.1530/ERC-11-0138. Print 2011 Oct. Endocr Relat Cancer. 2011. PMID: 21712344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

78 results

Results by year